intoplicine

This page covers all intoplicine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA topoisomerase 1, DNA topoisomerase 2-alpha, DNA topoisomerase I, mitochondrial.

Targets

DNA topoisomerase 1, DNA topoisomerase 2-alpha, DNA topoisomerase I, mitochondrial

Phase 2 pipeline (1)

• INTOPLICINE · Oncology
  INTOPLICINE works by binding to and inhibiting DNA topoisomerase 1, an enzyme that helps cancer cells replicate and repair their DNA.

Patent intelligence

• intoplicine patent landscape — aggregated cliff calendar, attackable patents, originator estates